Oral Paclitaxel Solution With Immunotherapy and Concurrent SBRT as Neoadjuvant Treatment for Older Adults With NSCLC

Clinical trial NCT07754812 · RECRUITING

Trial details

NCT number: NCT07754812
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

NSCLC (Non-small Cell Lung Cancer)

Start date: 2026-06-25
Primary completion: 2028-10-31
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.